You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
Effect of Zidovudine Postexposure Prophylaxis on the Development of HIV‐Specific Cytotoxic T‐Lymphocyte Responses in HIV‐Exposed Healthcare Workers
Ronnie D’Amico , DO, Ligia A. Pinto , MD, Peter Meyer , PhD, Alan L. Landay , PhD, Alan A. Harris , MD, Mario Clerici , MD, Jay A. Berzofsky , MD, PhD, Gene M. Shearer , PhD and Harold A. Kessler , MD
Infection Control and Hospital Epidemiology
Vol. 20, No. 6 (June 1999), pp. 428-430
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/501646
Page Count: 3
Preview not available
ABSTRACT We evaluated the effects of zidovudine postexposure prophylaxis (PEP) on the development of human immunodeficiency virus (HIV) envelope‐specific cytotoxic T‐lymphocyte responses in 20 healthcare workers with occupational exposures to HIV. Seven healthcare workers were treated with zidovudine PEP. Only 1 of 7 treated, versus 6 of 13 not treated, developed an HIV envelopespecific cytotoxic T‐lymphocyte response. These data suggest that zidovudine abrogated HIV‐specific cytotoxic T‐lymphocyte responses. HIV‐specific cytotoxic T‐lymphocyte responses may be useful as a surrogate marker of HIV replication in the evaluation of new regimens for PEP of occupational HIV exposures.
© 1999 by The Society for Healthcare Epidemiology of America. All rights reserved.